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O R I G I N A L  A R T I C L E
eratoconus is a corneal thinning disease that results 
in a focally reduced corneal radius of curvature, 
abnormal wavefront aberrations, and a localized 
reduction in corneal thickness and stiffness. These aber-
rations lead to a decline in visual function that ultimately 
may require corneal transplantation.1 Corneal cross-linking 
(CXL) with riboflavin and ultraviolet-A (UVA) is an estab-
lished treatment for progressive keratoconus and currently is 
the only therapeutic approach that is capable of significantly 
altering disease progression.2 Available for many years in 
Europe, this treatment option has been recently approved by 
the U.S. Food and Drug Administration for use in the United 
States.2 The so-called “Dresden” or “standard” protocol is the 
current standard approach for CXL for keratoconus and con-
sists of 30 minutes’ exposure to 3 mW fluence (5.4 mJ/cm2) 
following 30 minutes of soaking in 0.1% riboflavin.3 
The Dresden protocol involves removal of the corneal 
epithelium followed by dosing of the corneal stroma with 
KABSTRACT 
PURPOSE: To determine the relationship between me-
chanical behavior in cross-linked corneas and changes 
in the corneal ultrastructure after corneal cross-linking 
(CXL).
METHODS: Porcine corneas were treated following 
the “Dresden” protocol, the current gold standard for 
clinical treatment, consisting of dropwise application 
of 0.1% riboflavin in 20% dextran followed by 30 min-
utes of ultraviolet-A (UVA) irradiation. The effect of CXL 
was assessed using uniaxial tensile testing, transmis-
sion electron microscopy, and Fourier transform infrared 
spectroscopy, with results compared against corneas 
treated with each of the treatment solution components 
individually.
RESULTS: UVA/riboflavin cross-linked corneas displayed 
28% ± 17% increase in the material tangent modulus 
compared with dextran treatment alone, and altered 
collagen architecture within the first 300 µm of stromal 
depth consisting of 5% increase in the thickness of col-
lagen fibrils, no significant changes to interfibrillar spac-
ing, and an 8% to 12% decrease in number of fibrils 
per unit area. Fourier transform infrared spectroscopy 
confirmed formation of interfibrillar bonds (P = .012) 
induced by UVA-mediated CXL.
CONCLUSIONS: The data support a model wherein col-
lagen fibril diameter and structural density are funda-
mental parameters in defining tissue stiffening follow-
ing UVA/riboflavin CXL and provide benchmarks against 
which modifications to the Dresden CXL protocol can be 
evaluated.
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0.1% riboflavin in 20% dextran for 30 minutes, 
then exposure to ultraviolet light over a 30-minute 
period. The rationale behind this approach is that 
photo-polymerization, in the presence of the pho-
tosensitizer riboflavin, leads to creation of chemical 
bonds between substrates within the corneal stroma, 
including between collagens and proteoglycans and 
other stromal proteins.3-5 The effects of these induced 
cross-links have been variously reported as increases 
in tissue stiffness, resistance to enzymatic digestion, 
changes to ultrastructure, and altered swelling behav-
ior.6-9 However, these studies have generally evaluat-
ed the overall effects of the full CXL protocol without 
separating the contribution of individual aspects of 
the treatment and there are some differences in out-
comes reported.5,6,10,11
Mechanical properties of biological tissues are large-
ly dependent on the intertwining of collagen fibrils, 
linked lamina layers, and interfibrillar spacing.12-14 
Therefore, the efficacy of the Dresden CXL protocol is 
believed to be dependent on changes to the mechanical 
properties of the tissue induced through modifying the 
characteristics of collagen fibrils within the cornea and 
the induction of intrafibrillar bonds, with the overall 
level of effect being dependent on treatment depth.15,16 
Previous studies have attempted to evaluate mechani-
cal properties and the effective CXL penetration depth 
by specifically examining anterior and posterior cor-
neal layers.9,17,18 These studies demonstrated that the 
CXL effect is predominantly located within anterior 
stroma but did not specify the parameters that may be 
involved in determining and defining the amount of 
the tissue stiffening induced. Indeed, the relationship 
between the mechanical behavior of the cross-linked 
cornea and its ultrastructure is poorly explored, and 
the specific contribution of the dextran within the ri-
boflavin solution has not been reported.18,19
Numerous modifications to the Dresden protocol 
are being tested in clinical settings; therefore, defined 
knowledge of the effect of the current treatment regi-
men is needed to provide a benchmark against which 
these modifications can be compared and moreover for 
rationale design of alternative approaches. The current 
study aimed to improve this understanding by system-
atically investigating the role of dextran and the effect 
of UVA/riboflavin CXL in inducing mechanical and ul-
trastructural changes in the porcine cornea.
MATERIALS AND METHODS
CXL ProCedure and eXPerimentaL design 
Fresh porcine eyes were collected from an abattoir, 
washed with phosphate-buffered saline (PBS) (Sigma, 
Dorset, United Kingdom), the central corneas excised, 
and the corneal epithelium removed. To control for 
inter-animal variation, each cornea was cut into two 
segments in a superior-inferior fashion, with one being 
used as the test sample and the other for the control 
treatment (Figure A, available in the online version of 
this article).
There were four groups. The PBS vs PBS group (con-
trol) contained 6 corneas and each half cornea was topi-
cally treated with PBS in 3-minute intervals for 1 hour 
and used to examine the intrinsic differences between 
the two segments of each porcine cornea. The PBS vs 
riboflavin+PBS group contained 6 corneas and each cor-
neal segment was topically treated in 3-minute intervals 
for 1 hour with either PBS or 0.1% riboflavin (Sigma) 
prepared in PBS. The PBS vs riboflavin+dextran group 
contained 6 corneas and treatment was the same as for 
the PBS vs riboflavin+PBS group, except that the ribofla-
vin was prepared in 20% dextran (Sigma). The dextran 
vs riboflavin+dextran+UVA group contained 10 corneas 
and half were treated following the conventional Dres-
den protocol,3 with the anterior surface of the corneas 
treated with 5 mL of 0.1% riboflavin in 20% dextran 
at 3-minute intervals for 30 minutes, followed by UVA 
(370 nm) illumination at 3 mW/cm2 (Opto Xlink; Mehra 
Eyetech Pvt. Ltd., Delhi, India) for a further 30 minutes. 
Topical dosing of riboflavin with dextran drops was 
continued every 3 minutes during the UVA irradiation 
(for full CXL details following the standard convention, 
see Table 1).20 CXL corneas were compared to fellow 
segments treated with 20% dextran only.
Following treatment, the corneal tissues were dis-
sected for mechanical testing and for ultrastructural 
analysis (Figure A).
tensiLe testing
Corneal stiffness was examined using a uniaxial 
tensile tester (Instron 3366; Instron Engineering Cor-
poration, Norwood, MA), equipped with a 10N load 
cell. Two strips (3 mm width × 6 mm length) cut in the 
superior-inferior direction at the central cornea were 
inserted vertically into custom-designed clamps and 
the protocol set to apply a maximum loading stress of 
0.125 MPa, slightly above the stress expected under 
an intraocular pressure of 80 mm Hg.21 A constant ex-
tension of 1 mm/min was applied and the correspond-
ing stress (applied force divided by cross-sectional 
area) and strain (extension over original length) mea-
sured continuously. Five conditioning cycles,21 with 
4-minute recovery periods between two cycles, were 
performed. The tangent modulus (Et), the gradient of 
a tangent of the stress-strain behavior pattern, was cal-
culated at different stress levels to derive the overall 
stiffness of the tissue.22,23
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transmission eLeCtron miCrosCoPy (tem)
TEM was performed as described previously.6 
Briefly, the specimens were isolated from the central 
regions of cornea (Figure A) and fixed overnight with 
2.5% glutaraldehyde (TAAB Laboratories Equipment 
Ltd., Reading, United Kingdom) in 0.1% tannic acid. 
Thereafter, specimens were dissected into 1 × 2 mm 
blocks and incubated with 4% osmium (TAAB), fol-
lowed by serial dehydration through an acetone gradi-
ent (30%, 50%, 70%, 90%, and 100%) (Sigma). Speci-
mens were then infiltrated and embedded in medium 
resin (TAAB) and ultrathin 70-nm thickness sections 
cut using a diamond knife microtome and collected 
onto 200 mesh copper grids (Ted Pella, Inc., Read-
ing, CA). Sections were examined using a Tecnai G2 
spirit BioTWIN Transmission electron microscope 
(FEI Company, Hillsboro, OR) operated at 120 kV and 
60 k-fold magnification with a charge coupled device 
camera. Tissues were sampled at five depth intervals 
from the top of the anterior stroma: 0 to 50, 80 to 150, 
200 to 250, 300 to 350, and 400 to 450 µm.
Collagen fibrils in longitudinal, frontal, and oblique 
profiles were observed in TEM images; only those in 
frontal profiles were used for quantitative analysis with 
analyses performed using Fiji software (National Insti-
tutes of Health, Bethesda, MD). Ultrastructural param-
eters evaluated were: mean diameter of collagen fibrils, 
interfibrillar spacing, and number of fibrils per unit area. 
For mean diameter of collagen fibrils, circular spots in 
frontal profiles were isolated and exported and diam-
eters measured. The calculation of interfibrillar spacing 
was generated from Equation 1 while assuming that the 
collagen fibrils were evenly distributed: 
                                                                              (1)
Here R was defined as interfibrillar spacing (nm), D as 
mean diameter of collagen fibrils (nm), A as the area of 
selected zone of measurement (nm2), and N as the num-
ber of fibrils (circular spots) within the selected zone. 
The number of fibrils per unit area was determined by 
randomly localizing a window of fixed unit size (300 × 
300 nm) and the number of circular spots counted. 
The distribution curve of collagen fibrils was as-
sessed with a bespoke code using MATLAB 2016b 
software (The MathWorks, Inc., Natick, MA). Original 
images were converted to binary using adaptive thresh-
olding and a custom-designed collagen fibril detection 
system, using the Circular Hough Transform–based al-
gorithm,24,25 was established to analyze the radius of cir-
cular objects in frontal profiles of TEM images. Distribu-
tion curves were generated by plotting the frequency in 
2-nm increments against fibril radius. 
Fourier transForm inFrared (Ftir) absorPtion 
sPeCtrosCoPy 
Fresh porcine corneas were treated with either PBS, 
0.1% riboflavin in 20% dextran, or the full Dresden 
protocol (6 per group), lyophilized for 3 days, then 
measured with FTIR spectroscopy using a Nicolet 6700 
FTIR spectrometer (Thermo Fisher Scientific, Chelms-
ford, MA) with an attenuated total reflection module. 
Sixty-four accumulative scans were taken with a reso-
lution of 4 cm-1 between 800 and 4,000 cm-1. Data were 
collected using OMNIC software (Thermo Fisher Sci-
entific). Analyses of FTIR spectra of each condition 
were obtained with a combination of four spectral in-
tervals (y [C = O] absorption of amide I [1,680 to 1,630 
cm-1], d (NH2) absorptions of amide II [1,570 to 1,515 
cm-1], y [C – N] absorptions of amide III [1,350 to 1,200 
cm-1), and y [C – O] absorptions of carbohydrate moi-
eties [1,150 to 1,000 cm-1]). Area under the curve at 
each interval was analyzed using KnowItAll ID Expert 
software (Bio-Rad, Hercules, CA).
statistiCaL anaLysis 
Results for mechanical, ultrastructural, and FTIR 
spectra analyses are presented as mean ± standard 
deviation and statistical significance calculated using 
one-way analysis of variance with Turkey’s HSD post-
hoc tests. The Mann–Whitney U test (two-tailed) was 





Fluence (total) (mJ/cm2) 5.4
Soak time and interval (min) 30(q3)
Intensity (mW/cm2) 3
Treatment time (min) 30
Epithelium status Off
Chromophore Riboflavin  
(Sigma, Dorset, United Kingdom)
Chromophore carrier 20% dextran
Osmolarity Hypo-osmolar
Chromophore concentration 0.10%
Light source Opto Xlink  
(Mehra Eyetech Pvt. Ltd., Delhi, India)
Irradiation mode (interval) Continuous
CXL = corneal cross-linking
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tribution curves. P values of less than .05 were consid-
ered statistically significant.
RESULTS
UVA/riboflavin treatment and dextran-mediated 
dehydration both contribute to mechanical property 
changes in CXL. To isolate the effect of the individual 
components of UVA/riboflavin CXL, uniaxial tensile 
experiments and TEM were conducted on a set of por-
cine eyes split into paired comparison groups. To ac-
count for inter-animal variability, each cornea was cut 
in two and half treated with the treatment and com-
pared against the control (Figure A) (tensile measure-
ments and ultrastructural analyses were performed on 
the same cornea). Comparison groups were: PBS vs 
PBS, riboflavin+PBS vs PBS, riboflavin+dextran vs PBS 
and riboflavin+dextran+UVA vs dextran (Figure A).
The tangent modulus (Et) versus stress (s) for each 
corneal strip was determined and the overall stiffening 
effect indicated by the ratio of the tangent modulus (Etex-
perimental / Etcontrol). Comparisons concentrated on tangent 
modulus ratios at a stress of 0.03 MPa, which is equiva-
lent to a physiological intraocular pressure of approxi-
mately 25 mm Hg.21 As expected, no significant differ-
ences were observed where both corneal segments were 
treated identically with PBS, confirming the validity of 
our intra-eye control system (Etexperimental PBS vs Etcontrol PBS: 
1.36 ± 0.32 vs 1.43 ± 0.30 at 0.03 MPa, respectively, P = 
.075, Figures BA-BB, and Table A, available in the online 
version of this article). Riboflavin in PBS treatment also 
caused no stiffening (riboflavin in PBS: 1.45 ± 0.15 vs 
PBS: 1.38 ± 0.17, P = .448, Figure BC, Table A). However, 
the riboflavin+dextran group displayed a 13% ± 9% tan-
gent modulus increase compared to their internal PBS 
control (riboflavin in dextran: 1.52 ± 0.17 vs PBS: 1.34 ± 
0.18, P = .011, Figure BD, Table A). Comparing the effect 
of the full Dresden CXL protocol to the effect of dextran 
treatment alone, we observed a 28% ± 17% increase in 
tangent modulus in the corneal segments treated by the 
Dresden protocol (riboflavin+dextran+UVA: 2.09 ± 0.17 
vs dextran: 1.62 ± 0.18, P < .001, Figure BE, Table A).
The differences observed with dextran alone were 
somewhat surprising, but on comparing the tissue thick-
nesses following treatments, we observed statistically 
significant reduced thicknesses in the dextran-treated 
samples compared with their PBS controls that were 
indicative of dehydration (mean thickness riboflavin 
in dextran: 0.79 ± 0.04 mm, PBS: 1.05 ± 0.39 mm, P = 
1.39 × 10-6) (Figure BF, Table A). Correcting the tangent 
modulus readings with these thickness measurements 
removed the apparent dextran effects, whereas a residual 
stiffening effect was still observed in the samples treated 
with the Dresden protocol after correction (Figure BG). 
Together, these data demonstrate that dextran treatment 
alone causes dehydration and therefore an apparently in-
creased stiffening, whereas corneas treated with UVA/ri-
boflavin exhibit further increased stiffening beyond that 
caused by the dextran treatment alone.
uVa/riboFLaVin treatment Causes dePth-dePendent 
Changes to CoLLagen FibriL uLtrastruCture
Next, we measured changes to the collagen ultrastruc-
ture of specimens, measured at five different depth inter-
vals using TEM (Figure C, available in the online version 
of this article, and Figure BA; representative images at 
80 to 150 mm) and the obtained images were used to de-
termine collagen fibril diameter (Figure BB), interfibrillar 
spacing, and fibril number per unit area (density) (Table 
B, available in the online version of this article). The 
overall morphologies of the collagen ultrastructure did 
not change following PBS or riboflavin in PBS treatment 
in the absence of UVA (Figure C, Table B). However, the 
dextran treatment led to significantly thinner collagen fi-
brils (Figure 1A), as well as reduced interfibrillar spacing 
and denser packing at all depth intervals compared to its 
PBS control (Figure C). Because dextran also causes loss 
of tissue hydration, we used a mathematical method to 
correct for dehydration effects to identify the true struc-
tural changes.26 The relationship between thickness (T) 
and hydration (H) was modelled using the equation: T = 
0.2*e^(0.33*H), which has been shown to be effective for 
these types of calculation.26 The reduction in thickness 
followed an exponential decrease in tissue hydration, 
which we used to calculate the hydration state of the 
tissues and therefore calculate swelling factors at each 
depth interval (Table C, available in the online version 
of this article). Analysis of fibril diameter at each depth 
interval revealed that although dextran treatment caused 
a reduction in the frequency of large collagen fibrils com-
pared to PBS treatment (Figure 1B; 80 to 150 mm, Tables 
B-C) in the uncorrected data, when correction for swell-
ing factors was included, no significant differences were 
detected (Figure 1B, Figure D, available in the online 
version of this article), indicating that dextran treatment 
alone has no effect on collagen fibril diameter. 
In analyzing the effect of the Dresden UVA/riboflavin 
CXL protocol on corneal ultrastructure, both segments 
within our intra-eye comparisons were treated with 
dextran. Therefore, any residual difference between the 
internal controlled comparison groups reflected a true 
effect of the CXL procedure. Analysis revealed a small 
but statistically significant increase in collagen fibril di-
ameter in the CXL group at 80 to 150 µm (5% ± 2%, P < 
.01) and 200 to 250 µm depths (6% ± 3%, P < .01), with 
no differences observed at any other depth intervals 
(Figures 2C-2D, Figure D). No statistical differences in 
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interfibrillar spacing between treatments were observed 
at any depths (Figure 2E), but the Dresden protocol 
caused a decrease in the number of fibrils per unit area 
in the anterior 250 µm of the tissue (0 to 50 µm: 6% ± 
5%, P < .05; 80 to 150 µm: 11% ± 7%, P < .01; 200 to 250 
µm: 11% ± 5%, P < .01) (Figure 3, Table B). Together, 
these data indicate that the UVA/riboflavin CXL proce-
dure creates relatively small, depth-localized changes to 
the collagen ultrastructure.
indiViduaL uLtrastruCturaL measurements are 
insuFFiCient to PrediCt meChaniCaL Changes
Because we had performed the tangent modulus 
and ultrastructural measurements on the same eye 
(Figure A), we were able to directly compare the val-
ues obtained (Figure 3). Comparisons were made be-
tween mechanical outcomes measured at 0.03 MPa 
stress and structural parameters were determined 
from tissues in relaxed states. Collagen fibril diameter 
at 80 to 150 µm, intrafibril spacing increases, and col-
lagen fibril density decreases each displayed correla-
tion with tangent modulus increases across the test 
population (diameter: r2 =0.23, Figure 3A; spacing: r2 
= 0.39, Figure 3B; density: r2 = 0.52, Figure 3C). When 
percentage change on an individual eye basis was 
plotted, none of the individual ultrastructural param-
eters were independently indicative of the overall tis-
sue stiffness (Figure 3D). However, when considered 
in combination, the ultrastructural measurements 
performed better, with a positive correlation of 0.177 
(collagen fibril diameter + fibril density – interfibril-
lar spacing, Figure 3E). 
Figure 1. Transmission elec-
tron microscopy (TEM) images 
of porcine corneas imaged at 
a depth of 80 to 150 µm. (A) 
Representation TEM images of 
phosphate-buffered saline (PBS), 
riboflavin in dextran, and dextran 
only and riboflavin/dextran/ultra-
violet-A (UVA) cross-linked cor-
neas. Bar = 500 nm. (B) An area 
of 300 x 300 dpi (yellow dashed 
square) is shown at higher mag-
nification with an example of the 
measurement of the area and 
density of collagen fibrils. 
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Figure 2. Measurement of ultrastructural parameters and collagen fibril distribution at different depth intervals. (A) Mean collagen fibril diameters of 
phosphate-buffered saline (PBS) and riboflavin in dextran at each depth interval. (B) Collagen fibril diameter distributions plotted as either uncorrected 
values from the riboflavin+dextran group (top panel, black filled squares) or corrected for dehydration (top panel, gray squares) or its corresponding PBS 
control (middle panel, blue filled squares). Traces are shown overlaid in bottom panels. Gray filled background added to aid visualization. (C) Collagen 
fibril diameter distribution curve of corneal cross-linking group (green boxes) and its dextran control (black boxes) at each depth interval. (D) Relative 
collagen fibril diameter. (E) Relative interfibrillar spacing. (F) Relative collagen density of the corneal cross-linking group relative to its dextran group at 
each depth interval. Values are plotted as mean ± standard deviation from n = 6 (A and B) or n = 10 (C, D, E, and F). Asterisks denote significant 
differences from control groups, with *P < .05 and **P < .01. UVA = ultraviolet-A
270
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Ftir sPeCtrosCoPy reVeaLs the Formation oF new 
amide bonds in CXL Corneas
To assess the detailed chemical reactions and the 
conversion of chemical bonds within the corneal tissue 
after UVA/riboflavin CXL, FTIR spectroscopy measure-
ments were performed on corneas treated with either 
PBS, riboflavin+dextran, or riboflavin+dextran+UVA 
(Figures 4A-4B). The relevant characteristic bands 
were: amide I C = O stretching vibration (1,680 to 1,630 
cm-1), amide II NH2 bending vibration (1,570 to 1,515 
cm-1), amide III C-N stretching vibration (1,350 to 1,200 
cm-1), and C-O bond stretching vibration (1,150 to 1,000 
cm-1). The area under each band was calculated, and 
the deformation vibrations of CH2 (1,485 to 1,360 cm
-
1) were used as an internal standard to determine the 
intensity ratios (Figure 4C, Table D, available in the 
online version of this article). These analyses revealed 
significant increases in the C-O stretch peak, decreased 
C-N stretch, and increased NH2 deformation following 
CXL (Figure 4C). Plotting the ratio of C-N stretch to NH2 
deformation suggests that the decrease intensities of 
amide II infrared absorption bands are likely to be ac-
companied by an increase in the formation of amide III 
bonds (riboflavin+dextran+UVA = 2.5 ± 0.5; PBS = 1.7 ± 
0.3; riboflavin+dextran = 1.8 ± 0.2; Figure 4D, Table D). 
DISCUSSION 
In this study, we have characterized how corneal 
mechanical properties relate to ultrastructural changes 
following the Dresden protocol treatment and identi-
fied the contribution of the different components of 
the protocol to observed effects. Specifically, our data 
demonstrate that the increases in corneal stiffness 
measured following Dresden protocol treatment arise 
from a combination of dextran-mediated dehydration 
and UVA/riboflavin–induced new bond formation and 
depth-dependent increases in collagen fibril diameter.
Tissue stiffness is considered a combination of the 
internal geometry of the tissue and the properties of 
the material itself. Therefore, although our data indi-
cate that almost half of the measured stiffening effect 
of the Dresden protocol as measured ex vivo comes 
from the dextran component of the protocol, these ef-
fects can be explained by dehydration effects. How-
Figure 3. Correlation between ultrastructural parameters and tangent modulus. Tangent modulus at 0.03 MPa versus (A) collagen fibril diameter, (B) 
interfibrillar spacing, and (C) collagen fibril density. Black boxes = dextran-treated eyes; green boxes = riboflavin+ultraviolet-A (UVA)+dextran–treated 
eyes. (D) Percentage change in tangent modulus versus percentage change in each ultrastructural parameter. Each box represents the measurements 
from one eye for either fibril diameter (red), interfibril distance (orange), or fibril density (yellow). (E) Percentage change in tangent modulus plotted 
against the cumulative effects of percentage change in fibril diameter + interfibril spacing – fibril density. Each box represents one eye. Green line = 
linear line of best fit; red dotted line = 100% correlation
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ever, we did observe an increase in C-O stretching 
force in the riboflavin in the dextran-treated corneas 
compared with controls, indicating that dextran does 
itself induce collagen changes. A potential explana-
tion for these new bonds is that the dextran-induced 
dehydration increases the swelling pressure of tissue 
and therefore the resistance pressure of proteoglycan 
matrix,26,27 giving rise to intermolecular forces. These 
dextran and dehydration effects could help explain 
some of the apparently contradictory reports in the 
literature.5,6,10,11 Interestingly, tissue hydration states 
have been reported to affect the efficacy of CXL treat-
ment27; therefore, hydration states and the osmolarity 
of the riboflavin solutions could be important factors 
to consider in protocol modifications.
Our FTIR data revealed significant changes in C-O 
stretching force and conversion rate of amide bonds 
following the full Dresden protocol. Lysine-based 
cross-links following UVA/riboflavin CXL have previ-
ously been postulated but not been found chemical-
ly,3,28 and it has been proposed that cross-links form 
through endogenous carbonyl groups including im-
idazole formation.29 Our data support a model where 
the increased swelling pressure and the involvement 
of endogenous carbonyls (allysine) leads to the new 
bond formation.22 This leads to a broader mechanism 
where UVA/riboflavin–induced intrafibril bonds pres-
ent as thickened collagen fibrils and less dense overall 
structure and drive the increased tissue mechanical 
strength and resistance to dehydration (Figure E, avail-
able in the online version of this article). 
However, it should be noted that the ultrastructural 
changes we measured do not fully account for the me-
chanical effects, suggesting that collagen fibril diam-
eter and spacing are not the only aspects of stromal bi-
ology affected by UVA/riboflavin CXL. Effects on other 
stromal proteins and particularly the interactions of 
collagen with proteoglycans could be contributing to 
the stiffening. Proteoglycans within the corneal stroma 
have been proposed to play a pivotal role in regulat-
ing the fibril-fibril spacing and hydration-dehydration 
properties,30 but the dehydration-induced decrease in 
interfibril spacing has prevented us from being able 
to determine the sole effect of CXL on proteoglycans 
within our experimental system.  
Understanding the stabilization mechanism of UVA/
riboflavin CXL is clinically relevant when evaluating 
modifications to the Dresden protocol and developing 
Figure 4. Absorption Fourier transform infrared (FTIR) spectra of porcine corneas following corneal cross-linking treatments. (A) Representative FTIR 
spectra of corneas treated with phosphate-buffered saline (PBS) (bottom, gray), riboflavin+dextran (middle, black), or riboflavin+dextran+ultraviolet-A 
(UVA) (top, green). (B) Regions where the characteristic bands are located shown at higher magnification and regions of interest indicated amide I 
(1,680 to 1,630 cm-1), amide II (1,570 to 1, 515 cm-1), amide III (1,350 to 1,200 cm-1), and CO absorption band (1,150 to 1,000 cm-1). (C) Relative 
intensity ratio of each characteristic band and (D) conversion rate of amide II to amide III.  
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optimal protocols or new keratoconus treatments. This 
study establishes the standards in terms of mechanical, 
chemical, and structure/biological changes induced by 
the Dresden protocol and therefore provides the base-
line against which modifications can be judged.
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Figure A. Experimental scheme. Each cornea was cut into two segments 
in a superior-inferior fashion. The right-hand segment was used as an 
experimental segment, whereas the left-hand segment was used as its 
corresponding control. After each treatment, specimens were dissected 
and processed for tensile testing (green hollow rectangle) and transmis-
sion electron microscopy (TEM) (red hollow rectangle). S = superior; I = 
inferior; PBS = phosphate-buffered saline; UVA = ultraviolet-A
Figure B. The tangent modulus (Et) versus stress (s) behavior and ratio of tangent modulus of paired samples. (A) The tangent modulus vs stress 
behavior of right-hand corneal flaps vs left-hand flaps from 6 corneas are plotted. Both flaps were identically treated by soaking in phosphate-buffered 
saline (PBS). The ratio of tangent modulus between (B) PBS vs PBS (n = 6), (C) riboflavin+PBS vs PBS (n = 6), (D) riboflavin+dextran vs PBS (n = 
6), and (E) riboflavin+dextran+ultraviolet-A (UVA) vs dextran only (n = 10). Values from each individual cornea pair tested are indicated by gray lines. 
Average stiffening ratio ± standard deviation indicated by the bold line and error bars. The red dashed line represented the value of 1 (ie, no difference 
between paired samples). Gray shaded region in A-E plots represents 0.03 MPa. (F) Average thickness measurement of each comparison group after 
treatment. (G) The stiffening ratio at 0.03 MPa with and without correction for tissue thickness changes. Values in F and G denote mean ± standard 
deviation (SD). *P < .05. **P < .01. NS = not significant
TABLE A
Average Thickness and Stiffening Ratio at 0.03 MPa of Each Group  
Before and After Thickness Correctiona
Average Stiffening Ratio at 0.03 MPa Stressb





Etexperimental PBS/Etcontrol PBS 6 1,042 ± 52/1,050 ± 31 1.06 ± 0.07 1.04 ± 0.08
Etriboflavin+PBS/EtPBS 6 1,056 ± 38/1,053 ± 37 1.05 ± 0.14 1.04 ± 0.15
Etriboflavin+dextran/EtPBS 6 791 ± 40/1,047 ± 39 1.13 ± 0.09
b 1.09 ± 0.08
Etriboflavin+dextran+UVA/Etdextran 10 826 ± 60/813 ± 51 1.28 ± 0.17
b 1.29 ± 0.16b
aValues are presented as mean  ±  standard deviation. 
bP < .05 compared with its control.
Figure C. Transmission electron microscopy (TEM) images of porcine corneas imaged at different depth intervals following phosphate-buffered saline (PBS), 
dextran, and/or UVA/riboflavin treatment. Representative TEM images of (A) PBS, (B) riboflavin+PBS , (C) riboflavin+dextran, or (D) riboflavin+dextran+UVA 
and their corresponding controls at five depth intervals of 0 to 50, 80 to 150, 200 to 250, 300 to 350, and 400 to 450 µm. 
TABLE B
Mean Diameter, Interfibrillar Spacing, and Density of Collagen Fibrils  










Density of Collagen 
(N/900 nm2) 
PBS vs PBS 6 0 to 50 39.64 ± 1.13 vs 
38.69 ± 1.54
29.84 ± 2.12 vs  
30.25 ± 0.70
18.98 ± 1.56 vs 
19.56 ± 1.37
80 to 150 37.25 ± 1.10 vs  
36.41 ± 1.42
30.52 ± 1.64 vs  
30.78 ± 0.69
18.36 ± 1.17 vs  
19.25 ± 2.00
200 to 250 35.31 ± 1.15 vs  
34.84 ± 1.16
31.32 ± 1.71 vs  
30.03 ± 1.17
20.13 ± 1.56 vs 
20.47 ± 1.81
300 to 350 32.02 ± 1.08 vs  
32.02 ± 1.32
32.03 ± 1.49 vs  
31.31 ± 1.11
19.99 ± 2.08 vs 
19.93 ± 1.46
400 to 450 30.68 ± 0.89 vs  
30.27 ± 1.17
32.38 ± 1.26 vs  
31/52 ± 1.34
20.22 ± 2.59 vs 
19.55 ± 2.08
PBS vs riboflavin+PBS 6 0 to 50 38.63 ± 1.34 vs  
38.83 ± 1.11
30.24 ± 0.63 vs 
30.55 ± 0.94
19.70 ± 1.54 vs 
19.90 ± 1.04
80 to 150 35.61 ± 1.38 vs  
35.95 ± 0.66
30.75 ± 0.59 vs 
31.22 ± 1.48
19.47 ± 1.86 vs 
19.18 ± 2.00
200 to 250 34.34 ± 1.63 vs  
34.32 ± 1.15
30.65 ± 1.65 vs 
30.39 ± 0.98
20.06 ± 0.81 vs 
19.18 ± 2.00
300 to 350 31.18 ± 1.45 vs  
30.99 ± 0.92
31.38 ± 1.29 vs 
32.30 ± 0.76
21.42 ± 0.76 vs 
20.91 ± 1.19
400 to 450 30.28 ± 0.98 vs  
30.23 ± 0.52
31.10 ± 0.97 vs 
31.95 vs 1.70
21.17 ± 1.18 vs  
20.82 ± 1.48
PBS vs riboflavin+dextran 6 0 to 50 38.78 ± 1.68 vs  
34.68 ± 0.63**
30.83 ± 1.35 vs 
21.68 ± 2.20**
20.82 ± 1.23 vs 
28.42 ± 1.03**
80 to 150 36.02 ± 1.52 vs  
31.85 ± 0.97**
30.77 ± 1.13 vs 
21.59 ± 1.34**
18.82 ± 1.96 vs 
27.14 ± 1.82**
200 to 250 34.51 ± 1.11 vs  
30.36 ± 1.63**
30.49 ± 0.94 vs 
22.93 ± 1.69**
19.21 ± 1.42 vs 
28.20 ± 1.39**
300 to 350 31.11 ± 1.20 vs  
29.83 ± 0.86*
31.10 ± 0.92 vs 
23.41 ± 0.96
20.11 ± 1.24 vs 
26.40 ± 1.79
400 to 450 30.62 ± 1.92 vs  
29.45 ± 0.52
31.19 ± 1.21 vs 
23.95 ± 0.68**
20.15 ± 0.93 vs 
27.07 ± 1.17**
Dextran vs riboflavin+ 
dextran+UVA
10 0 to 50 35.85 ± 1.70 vs  
36.75 ± 1.03
20.53 ± 1.83 vs 
22.43 ± 3.49
20.03 ± 1.74 vs 
26.31 ± 1.42*
80 to 150 32.74 ± 1.39 vs  
34.32 ± 1.23**
21.93 ± 2.95 vs 
28.44 ± 2.95
28.44 ± 1.32 vs 
25.46 ± 1.71**
200 to 250 30.75 ± 1.05 vs  
32.50 ± 1.19**
22.52 ± 1.97 vs 
 23.37 ± 2.71
28.34 ± 1.41 vs 
25.24 ± 1.61
300 to 350 30.47 ± 1.36 vs  
30.46 ± 1.42
23.23 ± 1.81 vs 
22.11 ± 1.32
26.69 ± 1.94 vs 
27.03 ± 1.78
400 to 450 30.38 ± 1.17 vs  
30.21 ± 0.80
23.75 ± 1.68 vs 
22.89 ± 2.21
26.79 ± 1.77 vs 
27.34 ± 1.82
PBS = phosphate-buffered saline; UVA = unltraviolet-A 
aValues are presented as mean ± standard deviation. 
bP < .05 is indicated by an asterisk compared with its control. ** indicates increase compared with control, * represents decrease compared with control.
TABLE C
Area Ratio Corresponding to Indicated Characteristic Bands in FTIR Spectraa,b
Ratio PBS Riboflavin+Dextran Riboflavin+Dextran+UVA
No. of samples 6 6 6
C-O stretch/-(CH2)-deformation 1.08 ± 0.09 1.23 ± 0.12* 2.10 ± 0.55**
Amide II/-(CH2)-deformation 0.67 ± 0.08 0.64 ± 0.06 0.52 ± 0.08*
Amide III/-(CH2)-deformation 1.16 ± 0.02 1.19 ± 0.02 1.26 ± 0.04**
Amide I/-(CH2)-deformation 0.57 ± 0.09 0.50 ± 0.09 0.52 ± 0.10
Amide III/amide I 1.70 ± 0.33 1.84 ± 0.20 2.47 ± 0.51*
FITR = Fourier transform infrared spectroscopy; PBS = phosphate-buffered saline; UVA = ultraviolet-A 
aValues are presented as mean ± standard deviation. 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure E. Proposed model of ultraviolet-A (UVA)/riboflavin corneal cross-linking with the presence of dextran. The black solid circle, blue solid line, green 
solid line, and red solid line represent the collagen molecules, proteoglycans, original cross-links formed between collagen molecules, and additional 
cross-links induced by UVA/riboflavin corneal cross-linking treatment, respectively.
TABLE D
Parameters Used in Correction of the Collagen Fibril Radius Distribution Curves
Depth (µm)
Correction Parameter 0 to 50 80 to 150 200 to 250 300 to 350 400 to 450
Decreased % of collagen diameter 10.41% 12.83% 14.12% 4.18% 3.01%
Decreased % of interfibrillar spacing 29.03% 28.06% 27.39% 27.70% 26.91%
Decreased % of collagen diameter on overall loss 26.39% 31.01% 34.02% 13.11% 10.06%
Decreased % of interfibrillar spacing on overall loss 73.61% 68.99% 65.98% 86.89% 89.94%
Hydration loss % of collagen diameter 4.46% 5.24% 5.75% 2.21% 1.70%
Hydration loss % of interfibrillar spacing 12.45% 11.67% 11.16% 14.70% 15.21%
Remaining hydration % of collagen diameter 95.54% 94.76% 94.25% 97.79% 98.30%
Remaining hydration % of interfibrillar spacing 87.55% 88.33% 88.84% 85.30% 84.79%
Swelling factor for correction of distribution of collagen diameter 1.05 1.06 1.06 1.02 1.02
Overall tissue dehydration % = 16.91% (1.047 mm thickness/ 5.01; 0.791 mm/ 4.16). 
Thickness–hydration (T-H) relationship of porcine cornea: T = 0.2*e^(0.33*H). 
Swelling factor: 1 / Remaining tissue hydration
